Mitsubishi Tanabe Pharma issues its news to provide stakeholders with the latest information related to the Company. Information on products or drug candidates may be included, but is intended to provide for the media, etc. It is not intended for promotion, advertising or medical advice. Information is current as of the date of issue of the individual news. Please be advised that information may be outdated after that point.
Information Please beware of “spoofing e-mails, messages, etc.” that impersonate executives of Mitsubishi Tanabe Pharma Corporation (MTPC).
August 5, 2022
“Spoofing e-mails, messages, etc. “purporting to be from MTPC executives and proposing deals via e-mail or SNS have been confirmed. These “spoofing emails, messages, etc.” have no relation to MTPC.
Please be careful not to respond to suspicious emails or unexpected messages.